Consensus Stryker Corporation

Stocks

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 20:02:56 30/10/2026 GMT			5-day change	1st Jan Change
291.86 ^USD	-6.38%		-4.98%	-16.96%

10-30	Stryker's Q3 Miss Expected, But Negative Tone on Underperformance Unexpected, Truist Says	MT
10-30	Truist Adjusts Price Target on Stryker to $305 From $310	MT

Evolution of the Average Target: Stryker Corporation

Evolution of the Target Price: Stryker Corporation

Changes in Analyst Recommendations: Stryker Corporation

b193662.xg20pmLQ1KryFeXs1Y1Acx1JWLrKA5rXi3dqjF3iIZA.glf2_hqokOyoepKgjPQFGHBxPNOVTd2A6SAcwT-YSOaiacDhAJOF7KFGqA~7150e1f25f34cf6b84098a0e204e5fd2

Analysts' recommendations: Stryker Corporation

10-30	Truist Adjusts Price Target on Stryker to $305 From $310	MT
10-30	Truist Trims Price Target on Stryker to $305 From $310, Keeps Hold Rating	MT
10-30	BMO Capital Adjusts Price Target on Stryker to $309 From $317	MT
10-30	Deutsche Bank Adjusts Stryker Price Target to $275 From $315, Maintains Hold Rating	MT
10-30	RBC Cuts Price Target on Stryker to $375 From $420, Keeps Outperform Rating	MT
10-30	Barclays Adjusts Price Target on Stryker to $365 From $375	MT
10-30	Baird Adjusts Price Target on Stryker to $334 From $385	MT
10-30	Needham Adjusts Price Target on Stryker to $359 From $418	MT
10-30	JPMorgan Adjusts Price Target on Stryker to $340 From $350	MT
10-29	Not All AI Billions Are Equal
10-28	Evercore ISI Adjusts Stryker Price Target to $355 From $335	MT
10-12	BTIG Adjusts Price Target on Stryker to $316 From $358	MT
10-09	Leerink Partners Adjusts Stryker Price Target to $353 From $403	MT
10-06	Truist Securities Cuts Stryker Price Target to $310 From $340, Maintains Hold Rating	MT
10-06	Evercore ISI Adjusts Price Target on Stryker to $335 From $355, Keeps Outperform Rating	MT
10-06	Evercore ISI Adjusts Stryker Price Target to $335 From $355, Maintains Outperform Rating	MT
09-30	Stifel Adjusts Price Target on Stryker to $330 From $360, Maintains Buy Rating	MT
09-22	TD Cowen Adjusts Price Target on Stryker to $298 From $355, Keeps Hold Rating	MT
09-22	Jefferies Adjusts Price Target on Stryker to $405 From $440, Keeps Buy Rating	MT
09-21	Raymond James Adjusts Price Target on Stryker to $330 From $370, Keeps Outperform Rating	MT
09-18	Canaccord Genuity Adjusts Price Target on Stryker to $385 From $400, Keeps Buy Rating	MT
09-17	Stryker Facing Promising Setup Next Year, Trading Upside Limited in 2026, RBC Says	MT
09-14	Bernstein Adjusts Price Target on Stryker to $385 From $420, Keeps Outperform Rating	MT
09-09	Citigroup Adjusts Stryker Price Target to $360 From $399, Maintains Buy Rating	MT
09-09	Wells Fargo Adjusts Price Target on Stryker to $348 From $418, Keeps Overweight Rating	MT

More recommendations

Medical Devices & Implants

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	STRYKER CORPORATION					+20.07%
	ABBOTT LABORATORIES					+11.6%
	MEDTRONIC PLC					+8.36%
	ESSILORLUXOTTICA					+17.15%
	CENCORA, INC.					+12.34%
	HOYA CORPORATION					+16.9%
	BECTON, DICKINSON AND COMPANY					-1.17%
	IDEXX LABORATORIES, INC.					+25.98%
	ALCON INC.					+25.55%
	DEXCOM, INC.					+17.83%
	Average					+15.46%
	Weighted average by Cap.					+14.19%